美股異動 | 瑞信盤前漲2.6% 擬出售美國資管業務
格隆匯10月18日丨瑞信(CS.US)盤前漲2.64%,報4.67美元。市場消息,由於瑞信的投行和其他業務的估值低迷,阿布扎比和沙特阿拉伯都正尋求透過各自的主權基金注資瑞信。瑞信長期以來一直將富有的中東投資者視為主要股東,包括卡達投資局(QIA)和沙烏地的Olayan Group。另有消息指,瑞信集團可能重塑業務及其高層的戰略改革,正考慮出售其美國資產管理業務,該公司的投資銀行主管料將離職。分析預料,瑞信需要多達90億美元資金進行重組。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.